# US 2015/0104493 A1 · Dissolvable Strip for Treatment of Oral Thermal Burns

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2015/0104493 A1
- Document ID: US20150104493A1
- Status: Published application
- Kind: A1
- Application number: 14/573,420
- Filed: 2014-12-17
- Published: 2015-04-16
- Earliest claimed: 2012-10-22
- Inventors: Robert W. McDonald, III; Kurt Fraivillig; Adriane Shciano; Elizabeth Vansant; Lance Hansen
- Web page: https://patentgrep.com/patent/US20150104493A1

## CPC

- A61K 9/006: {Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays}
- A61K 31/045: Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K 31/167: having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
- A61K 31/245: Amino benzoic acid types, e.g. procaine, novocaine (salicylic acid esters A61K31/60)
- A61K 31/77: of oxiranes
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 9/7007: {Drug-containing films, membranes or sheets (A61K9/0041, A61K9/0043, A61K9/006, A61K9/0063 take precedence)}
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

A consumable film adapted to adhere and to dissolve in the oral cavity that provides a local anesthetic and therapeutic agents for the treatment of oral burns or injuries. The film is designed to instantly release benzocaine, or other types of local anesthetic or therapeutic agent, upon adhesion to the affected areas of the mouth, and will continue to release sufficient quantities for pain relief and for healing over an extended period of time.

## Claims

### Claim at position 1

-19. (canceled)

### Claim 20

A consumable, bioadhesive film adapted to adhere to a inside of the oral cavity for the treatment of thermal burns or an injury comprising:
mucoadhesive layer to hold the film onto the cheek of the oral cavity;
a rate-controlling polymer layer to deliver a first and second active ingredient over an extended period of time;
wherein at least one active ingredient is embedded in the polymer layer;
a drug barrier layer to restrict the direction in which drug release can occur.
wherein the polymer disintegrates over time;
wherein the first active ingredient is for the treatment of pain; and
a second active ingredient for the healing of said thermal burn or injury.

### Claim 21 (depends on 20)

The consumable film of claim 20 wherein the pharmaceutically active agent is selected from the group consisting of benzocaine, lidocaine, and menthol.

### Claim 22 (depends on 20)

The consumable film of claim 20 wherein the first pharmaceutically active agent is benzocaine.

### Claim 23 (depends on 22)

The consumable film of claim 22 wherein the benzocaine concentration is from about 0.1% to 20% by weight based on the total weight of the consumable film.

### Claim 24 (depends on 23)

The consumable film of claim 23 wherein the benzocaine concentration is about 10% by weight based on the total weight of the consumable film.

### Claim 25 (depends on 20)

The consumable film of claim 20 wherein the second pharmaceutically active agent is poloxamer 188.

### Claim 26 (depends on 25)

The consumable film of claim 25 wherein the poloxamer 188 concentration is at least 15% by weight based on the total weight of the consumable film.

### Claim 27 (depends on 26)

The consumable film of claim 26 wherein the benzocaine concentration is about 20% by weight based on the total weight of the consumable film.

### Claim 28 (depends on 20)

The consumable film of claim 20 further having a sweetener that is selected from the group consisting of: monosaccharides, disaccharides and polysaccharides, soluble saccharin salts, L-aspartic acid derived sweetening agents, thaumatoccous danielli (Thaumatin I and II), sucralose, aspartame, acesulfame potassium, neotame, saccharin, xylitol.

### Claim 29 (depends on 20)

The consumable film of claim 20 further including glycerol and HPMC.

### Claim 30 (depends on 29)

The consumable film of claim 29 wherein the glycerol is present in the amount of about 10%.

### Claim 31 (depends on 20)

The consumable film of claim 20 further including maltodextrin and sucralose.

### Claim 32 (depends on 20)

The consumable film of claim 20 further including food grade coloring.

### Claim 33 (depends on 20)

The consumable film of claim 20 further including an encasing selected from the group of pullulan, hydroxypropylmethyl cellulose (HPMC), hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinyl pyrrolidone, carboxymethyl cellulose, polyvinyl alcohol, sodium alginate, polyethylene glycol, tragacanth gum, guar gum, acacia gum, arabic gum, polyacrylic acid, methylmethacrylate copolymers, carboxyvinyl polymers, amylose, high amylose starch, hydroxypropylated high amylose starch, dextrin, pectin, chitin, chitosan, levan, elsinan, collagen, gelatin, zein, gluten, soy protein isolate, whey protein isolate, casein and mixtures thereof.

### Claim 34 (depends on 1)

A method for delivering an agent for pain relief and healing within the oral cavity for the treatment of thermal burns or oral injuries comprising administering the consumable film of claim 1 to the oral cavity.

### Claim 35

A method for producing a bioadhesive drug delivery film comprising:
by adding glycerol and slowly adding poloxamer 188 and stirring for approximately 3 to 5 minutes; and then adding benzocaine and heating and mixing at 60 degrees C. until the solution began to appeal clear or settled;
and then adding HPMC;
and then adding water in a drop-wise manner until the final solution was obtained.

### Claim 36 (depends on 35)

The method of claim 35 further comprising adhering a drug barrier layer to a portion of the bioadhesive film.
